Literature DB >> 334220

Laboratory investigation of effect of acute doses of nomifensine on a simulated aspect of night-time car driving performance.

I Hindmarch.   

Abstract

1. Six healthy volunteers received single doses of either nomifensine 100 mg, nomifensine 50 mg or placebo at weekly intervals in a randomized double-blind crossover study. 2. Subjects were subjected to a simulated test of car driving at night. 3. Testing lasted about 1.5 h and consisted of measuring responses to light stimuli, a modification of a test designed by Baker & Theologus (1972). 4. Nomifensine 100 mg reduced the latency of response significantly when compared with placebo (P less than 0.05). Nomifensine 50 mg had no significant effect. 5. It was concluded that nomifensine was unlikely to impair night driving performance.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 334220      PMCID: PMC1429132          DOI: 10.1111/j.1365-2125.1977.tb05748.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  5 in total

1.  Psychotropic drugs and impairment of psychomotor functions.

Authors:  A Penttilä; H Lehti; J Lönnqvist
Journal:  Psychopharmacologia       Date:  1975-07-23

2.  The effects of chlorpromazine and secobarbital on the C.P.T.

Authors:  A F MIRSKY; D W PRIMAC; R BATES
Journal:  J Nerv Ment Dis       Date:  1959-01       Impact factor: 2.254

3.  [Findings on the special psychological effect of the thymoleptic tofranil].

Authors:  E GRUNTHAL
Journal:  Psychiatr Neurol (Basel)       Date:  1958-12

4.  Effects of four commonly-used tranquillizers on low-speed driving performance tests.

Authors:  T A Betts; A B Clayton; G M Mackay
Journal:  Br Med J       Date:  1972-12-09

5.  Effects of caffeine on visual monitoring.

Authors:  W J Baker; G C Theologus
Journal:  J Appl Psychol       Date:  1972-10
  5 in total
  2 in total

1.  Dynamic interaction of nomifensine with alcohol.

Authors:  K Taeuber
Journal:  Br J Clin Pharmacol       Date:  1977       Impact factor: 4.335

2.  Nomifensine: A review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-07       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.